Patent details

EP2590630 Title: ORAL DOSAGE FORM OF DEFERASIROX

Basic Information

Publication number:
EP2590630
PCT Application Number:
PCT/EP/2011/003387
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117312686
PCT Publication Number:
WO/2012/003987
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ORAL DOSAGE FORM OF DEFERASIROX
French Title of Invention:
FORME DE DOSAGE ORALE CONTENAN DEFERASIROX
German Title of Invention:
ORALE DARREICHUNGSFORM FÜR DEFERASIROX
SPC Number:

Dates

Filing date:
07/07/2011
Grant date:
29/04/2015
EP Publication Date:
29/04/2015
PCT Publication Date:
12/01/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/05/2013
EP B1 Publication Date:
29/04/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/07/2015
Expiration date:
07/07/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/07/2011
 
 

Name:
ratiopharm GmbH
Address:
Graf-Arco-Strasse 3, 89079 Ulm, Germany (DE)

Inventor

1

Name:
RIMKUS Katrin
Address:
Germany (DE)

2

Name:
PAETZ Jana
Address:
Germany (DE)

Priority

Priority Number:
10007059
Priority Date:
08/07/2010
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 9/20;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages